Kelly Jared — Insider Stock Purchases
Chief Executive Officer. Every open-market stock purchase by Kelly Jared that we've tracked from SEC Form 4 filings, scored on our six-factor model. Not financial advice.
Tracked buys
2
Total value
$34,369
Most recent
Mar 12, 2026
| Ticker | Insider | Role | Value | Filed | Signal | Score |
|---|---|---|---|---|---|---|
| ONCY ONCOLYTICS BIOTECH INC | Kelly Jared | Chief Executive Officer | $4,848 | Mar 13, 2026 | WATCH | 45 |
| ONCY ONCOLYTICS BIOTECH INC | Kelly Jared | Chief Executive Officer | $29,521 | Feb 13, 2026 | WATCH | 46 |
About this profile
This page collects open-market share purchases disclosed by Kelly Jared in SEC Form 4 filings. When an insider buys with personal money on the open market, it is the cleanest conviction signal available — far more informative than a sale.
Each purchase is scored with our six-factor methodology. To see how these signals performed against the S&P 500, view the track record, or browse all tracked insiders on the insiders directory.
Not financial advice. For educational purposes only. Form 4 data can be amended or filed late; analysis is generated using AI and may contain errors.